In vivo studies indicate that CD8+ T cells from OT-1-LAG-3−/−Pdcd1−/− mice exhibit enhanced effector function and produce more inflammatory cytokines and suggest that LAG-3 and PD-1 synergistically promote immune tolerance in ovarian tumors [92]. Here, LAG3 is linked to ovarian neoplasm.